How does Pharma address clinical research #CancerEquity considerations so we can make sure our trials reflect actual reality of cancer patients? Panelists @ndenduluri1 @AstraZeneca Lisa Lewis @JanssenGlobal Patricia Velone @Novartis Meghan McKenzie @genentech & Dr. Colin Weekes

.@seunogunwobi taking precision medicine to the next level, as he detail how non-coding RNA can match unmet needs to address #CancerEquity through a multi-scale lens so lab work meets real applications for cancer patients.

.@CesarDepaz on how partnerships to enable language-and culturally-effective engagement—and making screening affordable to Latino/a communities—are practice ways faith communities can be a locus of support for #CancerEquity outreach w healthcare providers.

.@pastorglo as a physician-minister bring exhortation and data (h/t to #radonc @TracyABalboni) on meeting real needs of patients so spiritual care & cancer care work to, as @jjmlouis says, “come alongside” our patients journey to enable #CancerEquity

Are we holistically caring for cancer patients by understanding their spiritual needs? How should we partner w faith communities for #CancerEquity? @pastorglo @CesarDepaz @jjmlouis & Karen Burns-White define best practices and unmet needs: When we know better—“Do better!”

Drs. Robert Winn, William Blackstock, & Ruben Mesa panel at @MGHMedicine #CancerEquity Colloquium is a leadership seminar, delivering a vision & practical path for @theNCI Cancer Centers to actually deliver DEI interleaved as praxis w research, care and career development.

I feel like our US healthcare system is just so bad at getting effective care for everyone in the abstract, but the shared experience of these caregivers/families in the face of inequity in cancer care delivery is heartrending. @MGHMedicine #CancerEquity

.@MGHMedicine #CancerEquity Colloquium getting into the data w @UMassChan MD-PhD candidate Keeley Preval: Early *components* of pre-med URM mentorship increase application efficacy re: med school

CRT: Mentorship drives benefits for mentors as well as mentees…but white mentors can sometimes be “collectors” of URM trainees—important pitfall for #CancerEquity workforce development.

The great CRT @DHMC_RadOnc: #CancerEquity is facilitated by deliberate, stage-specific mentoring, using tools for self-assessment

The legendary Dr. Charles R. Thomas, Jr, sharing his wisdom on proactive, engaged mentorship as a path to #CancerEquity @MGHMedicine Colloquium: “Mentoring can be a team approach”

.@DrWinkfield : “We have to restructure the way we think of precision care”—multiscale and holistic measures are needed to achieve #CancerEquity.

“When we are precise, we see sub-populations @ risk”.

.@DrWinkfield at the @MGHMedicine #CancerEquity Colloquium on Equity in Precision Medicine—fantastic presentation, bringing slide after slide of 🔥 🔥; incisive and inspiring. Precision medicine is more than targeted drugs!! #radonc